Choice of units of analysis and modeling strategies in multilevel hierarchical models
DOI10.1016/J.CSDA.2003.12.003zbMATH Open1429.62482OpenAlexW1992510186WikidataQ59901709 ScholiaQ59901709MaRDI QIDQ957034FDOQ957034
Authors: José Cortiñas Abrahantes, Geert Molenberghs, Tomasz Burzykowski, Ziv Shkedy, Ariel Alonso Abad, Didier Renard
Publication date: 26 November 2008
Published in: Computational Statistics and Data Analysis (Search for Journal in Brave)
Full work available at URL: http://hdl.handle.net/1942/675
Recommendations
- The evaluation of surrogate endpoints.
- Hierarchical Selection Models With Applications in Meta-Analysis
- The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials
- Center-within-trial versus trial-level evaluation of surrogate endpoints
- Simplified modeling strategies for surrogate validation with multivariate failure-time data
Linear regression; mixed models (62J05) Applications of statistics to biology and medical sciences; meta analysis (62P10)
Cites Work
- Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points
- Title not available (Why is that?)
- Linear mixed models for longitudinal data
- Simplified hierarchical linear models for the evaluation of surrogate endpoints
- Influence diagnostics for generalized linear mixed models: applications to clustered data.
- A simulated pseudo-maximum likelihood estimator for nonlinear mixed models.
- Bayesian model comparison in generalized linear models across multiple groups.
- Bayesian and likelihood methods for fitting multilevel models with complex level-1 variation.
- The validation of surrogate endpoints in meta-analyses of randomized experiments
Cited In (10)
- Unbalanced cluster sizes and rates of convergence in mixed-effects models for clustered data
- Analysing multisource feedback with multilevel structural equation models: Pitfalls and recommendations from a simulation study
- On the relationship between the causal-inference and meta-analytic paradigms for the validation of surrogate endpoints
- Center-within-trial versus trial-level evaluation of surrogate endpoints
- Surrogate Marker Evaluation from an Information Theory Perspective
- Statistical evaluation of surrogate endpoints with examples from cancer clinical trials
- Flexible surrogate marker evaluation from several randomized clinical trials with continuous endpoints, using R and SAS
- Simplified modeling strategies for surrogate validation with multivariate failure-time data
- The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials
- Estimating negative variance components from Gaussian and non-Gaussian data: a mixed models approach
This page was built for publication: Choice of units of analysis and modeling strategies in multilevel hierarchical models
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q957034)